| __timestamp | Amphastar Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 1288519000 |
| Thursday, January 1, 2015 | 251519000 | 1465761000 |
| Friday, January 1, 2016 | 255165000 | 1598800000 |
| Sunday, January 1, 2017 | 240175000 | 1725300000 |
| Monday, January 1, 2018 | 294666000 | 1627800000 |
| Tuesday, January 1, 2019 | 322357000 | 1448800000 |
| Wednesday, January 1, 2020 | 349846000 | 1483300000 |
| Friday, January 1, 2021 | 437768000 | 1685500000 |
| Saturday, January 1, 2022 | 498987000 | 1936300000 |
| Sunday, January 1, 2023 | 644395000 | 2327500000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, United Therapeutics Corporation and Amphastar Pharmaceuticals, Inc. have showcased distinct revenue trajectories over the past decade. From 2014 to 2023, United Therapeutics has consistently outperformed Amphastar, with its revenue growing from approximately $1.3 billion to $2.3 billion, marking an impressive 80% increase. In contrast, Amphastar's revenue rose from $210 million to $644 million, a substantial 206% growth, albeit from a smaller base.
This comparison highlights the diverse strategies and market positions of these two companies, offering valuable insights into their financial health and future potential.
Revenue Showdown: Gilead Sciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Revenue Insights: Zoetis Inc. and United Therapeutics Corporation Performance Compared
Revenue Showdown: United Therapeutics Corporation vs Genmab A/S
Who Generates More Revenue? United Therapeutics Corporation or Exelixis, Inc.
Comparing Revenue Performance: United Therapeutics Corporation or Lantheus Holdings, Inc.?
United Therapeutics Corporation vs Cytokinetics, Incorporated: Examining Key Revenue Metrics
United Therapeutics Corporation and PTC Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: United Therapeutics Corporation and Supernus Pharmaceuticals, Inc. Performance Compared
Breaking Down Revenue Trends: United Therapeutics Corporation vs Celldex Therapeutics, Inc.
Genmab A/S and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
ACADIA Pharmaceuticals Inc. and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Amphastar Pharmaceuticals, Inc. and Xencor, Inc.: A Comprehensive Revenue Analysis